Cypress Bioscience

StockProfiler.US: Stock Profiler.US: News Update: CYPB & KNXA

tmcnet.com     Sep 4, 2008   1 related          

New York, NY -- Cypress Bioscience, Inc. (NASDAQ: CYPB); Kenexa (NASDAQ: KNXA) Stock Profiler welcomes investors to chat LIVE about these stocks and more on their upgraded website with FREE Investor Tools, Live Chats, and...                    

comments

Cypress Bioscience: About To Reverse Course? (at Seeking Alpha)

yahoo.com     Aug 21, 2008   1 related          

by: Badger The Lion posted on: August 21, 2008 | about stocks: CYPB ) is a favored stock for selling covered calls. But on Thursday (8/14) and Friday (8/15) last week, 1,000 Dec. call options and 1,000 Dec. put options at the...                    

comments

Google's Android Phone Gets Green Light From FCC

informationweek.com     Aug 21, 2008   1 related          

Startup Aims To Make The Workplace, And The World, Smarter Austhink Software of Australia has developed an application that it says can help employees not just work smarter, but become smarter. This isn't your typical business...                    

comments

                   

Cypress Bioscience, Inc. Announces Second Quarter 2008 Results (Marketwire)

yahoo.com     Aug 8, 2008   208 related          

SAN DIEGO, CA--(MARKET WIRE)--Aug 8, 2008 -- For the quarter ended June 30, 2008, the Company reported a net loss of approximately $4.0 million or $0.11 per share basic and diluted compared to net income of approximately $2.3...                    

comments

                   

Cypress swings to 2Q loss due to declining revenue

ibtimes.com     Aug 8, 2008   1 related          

SAN DIEGO - Drug developer Cypress Bioscience Inc. said Friday it swung to a loss in the second quarter, as revenue from collaborations fell sharply compared with a year ago. Cypress took a loss of almost $4 million, or 11...                    

comments

Cypress Bioscience, Inc. Announces Second Quarter 2008 Results

tmcnet.com     Aug 8, 2008   1,064 related          

SAN DIEGO, CA, August 8 / MARKET WIRE/ -- Cypress Bioscience, Inc. (NASDAQ: CYPB) today announced its financial results for the second quarter of 2008. For the quarter ended June 30, 2008, the Company reported a net loss of...                    

comments (1)

                   
yahoo.com: Andrew Wilkinson yahoo.com

Monday Options Outlook: XME, EWZ, GDX, MVL, CYPB, MOT, BID (at Seeking Alpha)

yahoo.com     Aug 4, 2008   1 related          

by: Andrew Wilkinson posted on: August 04, 2008 | about stocks: SPDR Metals and Mining ETF – Option traders appear to embrace the trope of demand erosion today, with volumes and volatilities elevated in a number of leading...                    

comments

Cypress Bioscience, Inc. to Present at Oppenheimer Small & Mid Cap Clinical & Regulatory...

yahoo.com     Jul 29, 2008   3 related          

SAN DIEGO, CA--(MARKET WIRE)--Jul 29, 2008 -- Cypress Bioscience, Inc. today announced that Michael R. Hufford, PhD, its Vice President of Corporate Development, will present at the Oppenheimer Small & Mid Cap Clinical &...                    

comments

Cypress Bioscience Awaits Two Key Catalysts (at Seeking Alpha)

yahoo.com     Jul 13, 2008   2 related          

by: Mike Havrilla posted on: July 13, 2008 | about stocks: CYPB / FRX ) is set for two major trading catalysts over the second half of this year in the form of a PDUFA decision date by the FDA on 10/31/08 for milnacipran in the...                    

comments

ACADIA Pharmaceuticals, Tessera Technologies and Cypress Bioscience lead small-cap volume in...

pharmiweb.co.uk     Jun 17, 2008          

ACADIA Pharmaceuticals Inc (Nasdaq:ACAD), Tessera Technologies (Nasdaq:TSRA) and Cypress Bioscience Inc (Nasdaq:CYPB) are among the most actively traded companies in Monday's trading among companies with market capitalizations...                    

comments

1 2 3 next